本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pacira Pharmaceuticals

24.89
+0.21500.87%
成交量:10.01萬
成交額:248.44萬
市值:9.92億
市盈率:70.74
高:25.04
開:24.60
低:24.49
收:24.67
52周最高:27.66
52周最低:18.80
股本:3,986.19萬
流通股本:3,636.93萬
量比:0.63
換手率:0.28%
股息:- -
股息率:- -
每股收益(TTM):0.3518
每股收益(LYR):0.1578
淨資產收益率:2.05%
總資產收益率:1.48%
市淨率:1.48
市盈率(LYR):157.67

資料載入中...

2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/04

重要事件披露

Form 8-K - Current report
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/09

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities